Bombardier, C <br/><br/>
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.  [electronic resource] 

 -  The New England journal of medicine  11 2000 
 - 1520-8, 2 p following 1528 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM200011233432103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Arthritis, Rheumatoid--drug therapy<br/>Cardiovascular Diseases--mortality<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--therapeutic use<br/>Duodenal Obstruction--chemically induced<br/>Female<br/>Gastric Outlet Obstruction--chemically induced<br/>Gastrointestinal Diseases--chemically induced<br/>Gastrointestinal Hemorrhage--chemically induced<br/>Humans<br/>Isoenzymes--antagonists & inhibitors<br/>Lactones--adverse effects<br/>Male<br/>Membrane Proteins<br/>Middle Aged<br/>Naproxen--adverse effects<br/>Peptic Ulcer--chemically induced<br/>Proportional Hazards Models<br/>Prostaglandin-Endoperoxide Synthases<br/>Sulfones